Version 25
Data Item #3942: CA 19-9 PreTX Lab Value

Length: 6
Source of Standard: NAACCR
Section Name: Stage/Prognostic Factors
Year Implemented: 2021
Version Implemented: 21
Record Types: A, M, C, I

XML NAACCR ID: ca199PretxLabValue

Parent XML Element: Tumor

Alternate Names:

Carbohydrate Antigen 19-9 Pretreatment Lab Value

Required Status:

NPCR Collect: . - No recommendations
CoC Collect: RS - Required, site specific
SEER Collect: R - Required
CCCR Collect: . - No recommendations

Description:

Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment. CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer.

Rationale:

CA 19-9 Pretreatment Lab Value is a strong predictor of resectability in the absence of metastatic disease. It is a new data item for cases diagnosed 01/01/2021+.

Item Data Type:

text

Allowable Values

0.0, 0.1-999.9, XXXX.1, XXXX.2, XXXX.3, XXXX.7, XXXX.8, XXXX.9, Blank

Codes:

0.0	0.0 Units/milliliter (U/ml) exactly
0.1-9999.9	0.1-9999.9 U/ml Exact value to nearest tenth in U/ml)
XXXX.1	10,000 U/ml or greater
XXXX.2	Lab value not available, physician states CA 19-9 is negative/normal
XXXX.3	Lab value not available, physician states CA 19-9 is positive/elevated/high
XXXX.7	Test ordered, results not in chart
XXXX.8	Not applicable: Information not collected for this case If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.
XXXX.9	Not documented in medical record CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value not assessed or unknown if assessed
Blank	Diagnosis year is prior to 2021

Code Notes:

Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.

Version 25 Data Item #3942: CA 19-9 PreTX Lab Value